Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
11/2006
11/08/2006EP1718760A1 Protein phosphorylation in c-src signaling pathways
11/08/2006EP1718668A1 Antibody purification
11/08/2006EP1718667A2 Heterocyclic self-immolative linkers and conjugates
11/08/2006EP1718664A2 Modified human four helical bundle polypeptides and their uses
11/08/2006EP1718662A2 Multiplex detection probes
11/08/2006EP1718339A2 Modified human interferon polypeptides and their uses
11/08/2006EP1636360A4 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
11/08/2006EP1263800B1 Linker based solid support for peptide and small molecule organic synthesis
11/08/2006CN1858228A Process for preparing low molecular peptide and amino acid by biological enzymolysis of pig blood haematoglobin
11/08/2006CN1858064A Chicken yoke antibody resisting Bengalese cobra venom and its preparation
11/08/2006CN1858061A Vacomycin column chromatography purifying method
11/08/2006CN1858060A Process for preparing solid phase polypeptide synthetic eptifibatide
11/08/2006CN1283792C Phase separation method for biomacromolecule components
11/08/2006CN1283778C Culture of Chansi mould strains and extraction and use of anagentic compound therefrom
11/08/2006CN1283664C Erythropoietin conjugate
11/08/2006CN1283660C Method for chromatographic removal of prions
11/07/2006US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006US7132519 Label for use as detection tool in mass spectrometry
11/07/2006US7132514 Electrophoresis and Western blotting to detect material which binds to capsid anti-protein monoclonal antibody
11/07/2006US7132508 Mammalian chemokine reagents
11/07/2006US7132507 Nucleotide sequences coding polypeptide for use in the treatment of cancer
11/07/2006US7132395 Contacting human rhinovirus with a polypeptide having a fragment of human rhinovirus major receptor (HRR) permit HRV to bind to the polypeptide; HRV is inhibited from infecting host cell.
11/07/2006US7132295 Isotopically coded affinity markers 3
11/07/2006US7132273 polynucleotides codes, cells transformed with genetic vectors and gene expression of heterologous polypeptides or proteins on the surfaces of cells; biochemical immobilization; biocatalysts; altering target protein characteristics such as binding affinity and stability by library screening
11/07/2006US7132269 Coupling agents, the active intermediates and the conjugates thereof and the use of said conjugates in diagnostic methods
11/07/2006US7132264 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
11/07/2006US7132107 For prophylaxis and therapy of prevention and pneumococcal infection
11/07/2006US7132102 Bacteriocin isolated from Lactobacillus salivarius deposited with United States Department of Agricultural, Agricultural Research Service Patent Culture Collection as Accession Number NRRL-B30514; used for reducing the levels of colonization by a target bacteria in animals, especially poultry
11/07/2006US7132101 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
11/07/2006US7132049 Negatively charged membrane
11/07/2006CA2454605C Immunoaffinity isolation of modified peptides from complex mixtures
11/02/2006WO2006114528A1 Method of preparing grafted polylysine dendrimers
11/02/2006WO2006114039A1 Method for separating nisin from fermantation liquid of lactic galactococcus
11/02/2006WO2006113959A2 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein
11/02/2006WO2006113958A2 Affinity ligands
11/02/2006US20060247426 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment
11/02/2006US20060247417 Labelling peptides with hydrazide/hydrazine moieties
11/02/2006US20060247157 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides
11/02/2006US20060246549 Peptide acceptor ligation methods
11/02/2006US20060246465 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/02/2006US20060246461 Nucleotide sequence coding membrane protein; diagnosis of tumor, cancer
11/02/2006EP1717581A1 Method of chemical substance separation
11/02/2006EP1715948A2 Chromatographic material for the absorption of proteins at physiological ionic strength
11/02/2006EP1597383A4 Variants of cytochrome c and methods of diagnosis of thrombocytopenia
11/02/2006EP1554237A4 Methods for synthesis of acyloxyalkyl derivatives of gaba analogs
11/02/2006EP1147137B9 Methods for generating phosphorylation site-specific immunological reagents
11/02/2006EP1042443B1 Granule with hydrated barrier material
11/02/2006EP0958501B1 Method for screening substances with therapeutic action in the treatment of transmissible subacute spongiform encephalopathy
11/02/2006EP0873361B1 Crystals of the ligand-binding domain of the thyroid hormone receptor complexed to a ligand
11/02/2006CA2606240A1 Method of preparing grafted polylysine dendrimers
11/02/2006CA2605145A1 Affinity ligands
11/01/2006CN1856504A Anti-infarction molecules
11/01/2006CN1856345A Conjugates of magnetic polymer particles and carboxymethylated aspartic acid
11/01/2006CN1856343A Fractal-forming alkylketene dimers for integral membrane protein crystal growth
11/01/2006CN1854295A Production of specific micro-antibody for oarium cancer
11/01/2006CN1854294A Escherichia expression system of secretory expression recombinant human epidermal growth factor
11/01/2006CN1854155A Purification of rHSA
11/01/2006CN1854152A Method for desorbing and recovering lactic acid chain coccus peptide
11/01/2006CN1854150A Factor VIII separation
11/01/2006CN1854121A Bamboo shoots amino acid peptide extract its production and use
11/01/2006CN1282655C Soybean protein solution and its preparing method
10/2006
10/31/2006US7129331 Phosphorylated polypeptides and uses related thereto
10/31/2006US7129328 Liver tumor marker sequences
10/31/2006US7129327 Polypeptide and protein derivatives and process for their preparation
10/31/2006US7129210 cross-linkable protein in the form of a solution or suspension; cross-linking agent solution includes an aldehyde and an amino acid containing species reactive with the aldehyde
10/31/2006US7129203 Deleting at least one amino acid residue on the protein, and contacting the protein with polyethylene glycol under conditions sufficient to conjugate the polyethylene glycol to the protein
10/31/2006US7129057 Human testis specific serine/threonine kinase 3
10/31/2006US7128913 Erythropoietin conjugates
10/31/2006CA2250047C Monoclonal antibodies binding human growth hormone (hgh)
10/26/2006WO2006111060A1 A method for isolating and purifying immuno-modulating polypeptide from cow placenta
10/26/2006WO2006085984A9 Immune cell biosensors and methods of using same
10/26/2006WO2006003330A3 Collections of traceable compounds and uses thereof
10/26/2006WO2005062788A3 Prostate specific proteins expressed in cancer and methods of use thereof
10/26/2006WO2002101008A3 Intracellular signaling molecules
10/26/2006WO2002078420A3 Molecules for disease detection and treatment
10/26/2006US20060241283 Volatilizable solid phase supports for compound synthesis
10/26/2006US20060241282 synthesis of long peptides (over 20 amino acid residues) or for peptides where synthesis is problematic on 2-chlorotritylchloride resin; first resin is chosen so that it does not lead to the formation of cyclic dipeptides and in particular to the formation of diketopiperazine compounds
10/26/2006US20060241055 Peptides promoting cell adherence, growth and secretion
10/26/2006US20060241020 Protein tyrosine phosphatase inhibitors
10/26/2006US20060241016 For isolating low molecular weight peptides from animal tissue; prevention of initial dissolution of higher molecular weight fraction proteins by in situ denaturation within the tissue, by an organic solvent (preferably ethanol), prior to aqueous extraction
10/26/2006US20060240510 Method for designing peptides
10/26/2006US20060240474 Peptides able to switch between two structural states and their use
10/26/2006US20060240036 I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis
10/26/2006US20060240030 Anti-hiv immunogenic formulation and process for preparation thereof
10/26/2006CA2602635A1 Method of altering the binding specificity of proteins by oxidation-reduction reactions
10/25/2006EP1714982A2 Methods for purifying highly anionic proteins
10/25/2006EP1714981A2 Method for the identification of antigenic peptides
10/25/2006EP1714972A2 Method for producing a peptide with a pl above 8 or below 5
10/25/2006EP1713821A2 Primary central nervous system tumor specific behab isoforms
10/25/2006EP1713723A2 Fullerene based amino acids
10/25/2006EP1095054B1 Method of using an improved peptide nucleic acid universal library to optimize dna sequence hybridation
10/25/2006CN1852765A Compositions for separating molecules
10/25/2006CN1852736A Immunoglobulin chimeric monomer-dimer hybrids
10/25/2006CN1850858A Method for purifying mouse herve growth factor for scale-production
10/25/2006CN1850854A Method for extracting glutathione from glutathione fermented broth
10/25/2006CN1281624C Thrombin derivatives and its process for production
10/25/2006CN1281617C Method for separating human plasma protein fraction by press filtration process
10/24/2006US7125960 crosslinked elastin having elasticity suitable for transplantation into the body while avoiding detachment of the coated cell adhesion proteins such as collagen or laminin
10/24/2006US7125958 membrane proteins acting as binding ligands to mucopolysaccharide receptors for antigens present on the surfaces of palsmodium infected erythrocytes; drugs; antibodies
10/24/2006US7125956 Peptide fragment of interleukin 1 beta converting enzyme (ICE) itself as ICE inhibitors; peptide is linked to an agent capable of specifically directing the compound to a cell such as fragment of Antennepedia polypeptide, an antibody, an adjuvant or a cell-specific ligand; neurodegenerative disorders